Skip to main content
. 2022 Sep 8;60(1):1690–1700. doi: 10.1080/13880209.2022.2112239

Figure 5.

Figure 5.

Kirenol could improve GBM thickness and podocyte failure. (A) TEM showed that kirenol alleviated diabetes-induced foot process fusion and podocytes diminish. Red arrows indicate foot process and black arrow indicate foot process effacement. (B) Quantitative analysis of GBM thickness (nm). Data are expressed as mean ± SEM. *p < 0.05 vs. control group, #p < 0.05 vs. DM group.